European Medicines Agency (EMA) | What's new

Orphan designation: 3-(3-(3,5-Dimethyl-1H-pyrazol-4-yl)propoxy)-4-fluorobenzoic acid Treatment of ATTR amyloidosis, 19/11/2018 Withdrawn

favicon
ema.europa.eu
ema.europa.eu
Create attached notes ...